Senior Vice President and Chief Financial Officer

Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results

Vaxxas appoints veteran vaccine leader to board as it advances needle-free vaccine patch

Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Towards Market

Dynavax enters license agreement for Vaxart's oral COVID-19 vaccine program Vaxart

IDN Key Account Executive II

Dynavax Technologies is a commercial-stage biopharmaceutical company focused on developing and commercializing novel vaccines for infectious diseases. The IDN Key Account Executive II will manage assigned accounts to drive sales of HEPLISAV-B, requiring deep understanding of vaccine decision-making and the ability to develop strategic relationships with key stakeholders.

IDN Key Account Executive II - Los Angeles South, CA

Associate Director, Human Resources

Chief Human Resources Officer

National Account Director

Key Account Executive

Sign up with Google

Sign in with Google